Res Treat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Res treat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Res Treat Today - Breaking & Trending Today

Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer

Biliary tract cancers have increased in incidence in many parts of the world, particularly
cases of intrahepatic disease.1,2 The incidence of cholangiocarcinoma varies geographically,
with 1·6 cases per 100 000 people in the USA, for example, but substantially higher
rates in parts of east Asia.2 Most patients present with advanced disease not amenable
to surgery and require systemic therapy. For more than 10 years, gemcitabine and cisplatin
was the internationally accepted first-line treatment for patients with locally advanced
and metastatic biliary tract cancer, as per the ABC-02 study. ....

United States , Gastroenterol Hepatol , European Network For The Study Of Cholangiocarcinoma , European Network , Rev Gastroenterol Hepatol , Res Treat , Drug Administration ,

Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement

Combined advances in haematopoietic cell transplantation (HCT) and intensive care
management have improved the survival of patients with haematological malignancies
admitted to the intensive care unit. In cases of refractory respiratory failure or
refractory cardiac failure, these advances have led to a renewed interest in advanced
life support therapies, such as extracorporeal membrane oxygenation (ECMO), previously
considered inappropriate for these patients due to their poor prognosis. Given the
scarcity of evidence-based guidelines on the use of ECMO in patients receiving HCT
and the need to provide equitable and sustainable access to ECMO, the European Society
of Intensive Care Medicine, the Extracorporeal Life Support Organization, and the
International ECMO Network aimed to develop an expert consensus statement on the use
of ECMO in adult patients receiving HCT. ....

South Korea , United States , France General , Scott Stephens , Civriz Bozda , Grupo Espa , Trasplante Hematopoyetico , Garcia Borrega , J Thorac Cardiovasc , Ann Hematol , Semin Thromb Hemost , Extracorporeal Life Support Organization Task , European Society Of Intensive Care Medicine , Extracorporeal Life Support Organization Maastricht Treaty , Marrow Transplant Research , Extracorporeal Life Support Organization Ecmoed Taskforce , International Blood , American Society For Transplantation , Lancet Child Adolesc Health , European Society Of Paediatric , Society Of Critical Care Medicine , Extracorporeal Life Support Organization , Extracorporeal Life Support Organization Registry , Health Sci Rep , Paris International Conference , Marrow Transplant ,

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers
ecancer.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ecancer.org Daily Mail and Mail on Sunday newspapers.

South Korea , United Kingdom , United States , Cheju Do , City Of , J Gastroenterol Hepatol , Gareth Morgan , Clin Gastroenterol Hepatol , Janet Pickering , Delyth Morris , Peterc Elwood , Christine Delon , Julieta Galante , Alison Weightman , Gynaecol Reprod , Majd Protty , J Clin Diagn , Gastroenterol Hepatol , John Watkins , Cardiff University , Kaiser Permanente Research Affiliates Practice Center , Cancer Research , Public Health , University Of Cambridge , Department Of Health , Us Preventive Services Task ,

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Sofiya Grad , United States , Stara Zagora , Comunidad Autonoma De Cataluna , American Association For Cancer Research Annual Meeting , European Society For Medical Oncology , Clin Oncol , Englj Med , Thorac Oncol , Cancer Res , Cancer Research Annual , Stat Theory Methods , Res Treat , Lung Cancer , Rev Clin Oncol , சோஃபியா கிரத் , ஒன்றுபட்டது மாநிலங்களில் , காமுனிடட தன்னாட்சி டி கடலுள் , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி ஆண்டு சந்தித்தல் , ஐரோப்பிய சமூகம் க்கு மருத்துவ புற்றுநோயியல் , புற்றுநோய் ரெஸ் , புற்றுநோய் ஆராய்ச்சி ஆண்டு , ஸ்ட்யாட் கோட்பாடு முறைகள் , ரெஸ் உபசரிப்பு , நுரையீரல் புற்றுநோய் ,